Pasteur Institute of India

Last updated

Pasteur Institute of India. Pasteur Institute of India 1.jpg
Pasteur Institute of India.

Pasteur Institute of India, Coonoor is one of the pioneer institutes in India in the production of Anti Rabies Vaccine (dog bite vaccine) and DPT vaccine (triple antigen) for the Expanded Programme of Immunization of Government of India. This institute started functioning as Pasteur Institute of Southern India, on 6 April 1907 and was officially opened by H. E. Sir Arthur Lawley, Governor of Madras, on 25 April 1907. The first President of the Society is Surgeon-General W.R. Browne, C.I.E., I.M.S., Surgeon-General with the Government of Madras. The first Honorary Secretary cum Director is Captain J.W. Cornwall, I.M.S., in his remembrance, the road starting from the adjacent area of main gate of the Pasteur Institute of India to Alwarpet named as Cornwall Road. The institute later renamed as Pasteur Institute of India (registered as a society under the Societies Registration Act 1860) and started functioning as an autonomous body under the Ministry of Health and Family Welfare, Government of India, from 10 February 1977. The affairs of the institute are managed by a governing body.

Contents

Genesis

The death of a young English lady Lily Pakenham Walsh, due to hydrophobia in the year 1902, who could not get anti-rabies treatment in time, led to the establishment of Pasteur Institute of Southern India. Henry Phipps, American philanthropist donated to Lord Curzon, the then Viceroy of India a sum of Rs.50.00 lakhs for the development of Medical Institutions, out of which, a sum of Rupees one lakh was allocated to start the Pasteur Institute of Southern India at Coonoor. The cool and equitable climate led to the choice of Coonoor as the most suitable location for the construction of the institute. Spread over an area of 16 acres of land the institute is situated on a grassy knoll on the upper reaches of Coonoor town amidst beautiful surroundings with lush greenery, manicured lawns and flower gardens. It has a glorious tradition of single minded dedication to alleviate the suffering of humanity by its contribution to the research and development of vaccines in the country.

Functions

Main Building of Pasteur Institute of India taken during Golden Jubilee Pasteur Institute of India.jpg
Main Building of Pasteur Institute of India taken during Golden Jubilee

Pasteur Institute of India, Coonoor is producing Vero Cell Derived Rabies Vaccine for Human use and DPT group vaccines consisting

(i) DPT Vaccine
(ii) DT Vaccine and
(iii) TT Vaccine supplying to Universal Immunization Programme (UIP).

Pasteur Institute of India, Coonoor is running Anti Rabies treatment centre 24x7 basis since its inception and it is well known for their academic activities like one week, one month for life science students and three months dissertation programmes to Post Graduate students.

Pasteur Institute of India, Coonoor running a Rabies Diagnostic Laboratory by RFFIT method. RFFIT stands for Rapid Fluorescent Focus Inhibition Test. It is a serum neutralization (inhibition) test, which means it measures the ability of rabies specific antibodies to neutralize rabies virus and prevent the virus from infecting cells. These antibodies are called Rabies Virus Neutralizing Antibodies (RVNA).

Pasteur Institute of India, Coonoor also offer Ph.D. and M.Phil. in Microbiology, Biochemistry and Biotechnology. Pasteur Institute of India, Coonoor Institute affiliated with Bharathiar University, Coimbatore for Ph.D.,

Pasteur Institute of India, Coonoor is also affiliated with Dr. M. G. R. Medical University, Madras for M.D. Microbiology.

During 2007–2008, the production licence of this institute was suspended by Union Government of India along with other public sector vaccine production Institutes namely Central Research Institute, Kasauli and BCG Vaccine Laboratory, Chennai. Later during 2010, the suspension was revoked and Union Government of India allocated about Rs.137 crores to establish a new GMP facility for the production of DPT group of vaccines. [1] [2] After suspension of licence, Pasteur Institute of India, Coonoor produced 494.30 lakh doses of DPT vaccines in the existing facility during the year 2012–13 to 2014–15. Now the facilities are running and expected that they will supply vaccines to UIP by December, 2021.

Origin of National Institute of Nutrition, Hyderabad

National Institute of Nutrition (NIN) was founded by Sir Robert McCarrison in the year 1918 as ‘Beri-Beri’ Enquiry Unit in a single room laboratory at the Pasteur Institute of India, Coonoor, Tamil Nadu. Within a short span of seven years, this unit blossomed into a "Deficiency Disease Enquiry" and later in 1928, emerged as full-fledged "Nutrition Research Laboratories" (NRL) with Dr. McCarrison as its first director. It was shifted to Hyderabad in 1958. [3]

WHO Influenza centre

In 1950, responding to an invitation by the World Health Organization to all its Member States to establish regional laboratories for the study, in collaboration with the World Influenza Centre, of the distribution and antigenic pattern of influenza viruses, the Government of India set up an Influenza Centre at the Pasteur Institute of Southern India, Coonoor. [4]

Current activities

During the recent outbreak of COVID-19, Pasteur Institute of India, Coonoor has carry out COVID - 19 testing with the approval of Indian Council of Medical Research [5] and Ministry of Health and Family Welfare.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Vaccine</span> Pathogen-derived preparation that provides acquired immunity to an infectious disease

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future.

<span class="mw-page-title-main">DNA vaccine</span> Vaccine containing DNA

A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence into the cells of an organism as a mechanism to induce an immune response.

<span class="mw-page-title-main">Immunization</span> Process by which an individuals immune system becomes fortified against an infectious agent

Immunization, or immunisation, is the process by which an individual's immune system becomes fortified against an infectious agent.

<span class="mw-page-title-main">Pasteur Institute</span> French disease research organization

The Pasteur Institute is a French non-profit private foundation dedicated to the study of biology, micro-organisms, diseases, and vaccines. It is named after Louis Pasteur, who invented pasteurization and vaccines for anthrax and rabies. The institute was founded on 4 June 1887, and inaugurated on 14 November 1888.

<span class="mw-page-title-main">Rabies virus</span> Species of virus

Rabies virus, scientific name Rabies lyssavirus, is a neurotropic virus that causes rabies in humans and animals. Rabies transmission can occur through the saliva of animals and less commonly through contact with human saliva. Rabies lyssavirus, like many rhabdoviruses, has an extremely wide host range. In the wild it has been found infecting many mammalian species, while in the laboratory it has been found that birds can be infected, as well as cell cultures from mammals, birds, reptiles and insects. Rabies is reported in more than 150 countries on all continents, with the exclusion of Antarctica. The main burden of disease is reported in Asia and Africa, but some cases have been reported also in Europe in the past 10 years, especially in returning travellers.

Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines. It is one of four global producers of the yellow fever vaccine.

Artificial induction of immunity is immunization achieved by human efforts in preventive healthcare, as opposed to natural immunity as produced by organisms' immune systems. It makes people immune to specific diseases by means other than waiting for them to catch the disease. The purpose is to reduce the risk of death and suffering, that is, the disease burden, even when eradication of the disease is not possible. Vaccination is the chief type of such immunization, greatly reducing the burden of vaccine-preventable diseases.

<span class="mw-page-title-main">H5N1 vaccine clinical trials</span>

H5N1 clinical trials are clinical trials concerning H5N1 vaccines, which are intended to provide immunization to influenza A virus subtype H5N1. They are intended to discover pharmacological effects and identify any adverse reactions the vaccines may achieve in humans.

<span class="mw-page-title-main">Antonio Lanzavecchia</span> Italian and Swiss immunologist

Antonio Lanzavecchia is an Italian and Swiss immunologist. As a fellow of Collegio Borromeo he obtained a degree with honors in Medicine in 1976 from the University of Pavia where he specialized in Pediatrics and Infectious Diseases. He is Head Human Immunology Program, Istituto Nazionale di Genetica Molecolare-INGM, Milan and SVP Senior research Fellow, Humabs/Vir Biotechnology, Bellinzona and San Francisco (USA). Since 2017, he is also Professor at the Faculty of Biomedical Sciences of the Università della Svizzera italiana (USI).

<span class="mw-page-title-main">Rabies vaccine</span> Vaccines to prevent rabies in humans and animals

The rabies vaccine is a vaccine used to prevent rabies. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies before, and, for a period of time, after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.

<span class="mw-page-title-main">Vaccine Research Center</span>

The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.

<span class="mw-page-title-main">Inactivated vaccine</span> Vaccine using a killed version of a disease pathogen

An inactivated vaccine is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and then killed to destroy disease-producing capacity. In contrast, live vaccines use pathogens that are still alive. Pathogens for inactivated vaccines are grown under controlled conditions and are killed as a means to reduce infectivity and thus prevent infection from the vaccine.

A neutralizing antibody (NAb) is an antibody that defends a cell from a pathogen or infectious particle by neutralizing any effect it has biologically. Neutralization renders the particle no longer infectious or pathogenic. Neutralizing antibodies are part of the humoral response of the adaptive immune system against viruses, intracellular bacteria and microbial toxin. By binding specifically to surface structures (antigen) on an infectious particle, neutralizing antibodies prevent the particle from interacting with its host cells it might infect and destroy.

SAV001-H is the first candidate preventive HIV vaccine using a killed or "dead" version of the HIV-1 virus.

Universal Immunisation Programme (UIP) is a vaccination programme launched by the Government of India in 1985. It became a part of Child Survival and Safe Motherhood Programme in 1992 and is currently one of the key areas under National Rural Health Mission since 2005. The programme now consists of vaccination for 12 diseases- tuberculosis, diphtheria, pertussis, tetanus, poliomyelitis, measles, hepatitis B, diarrhoea, Japanese encephalitis, rubella, pneumonia and Pneumococcal diseases. Hepatitis B and Pneumococcal diseases were added to the UIP in 2007 and 2017 respectively. The cost of all the vaccines are borne by the state and the government spent 3,587 crore (US$450 million) in 2017 to purchase the vaccines to provide them for free.

<span class="mw-page-title-main">H5N1 vaccine</span> Vaccine designed to provide immunity against H5N1 influenza

A H5N1 vaccine is an influenza vaccine intended to provide immunization to influenza A virus subtype H5N1.

Cell-based vaccines are developed from mammalian or more rarely avian or insect cell lines rather than the more common method which uses the cells in embryonic chicken eggs to develop the antigens. The potential use of cell culture techniques in developing viral vaccines has been widely investigated in the 2000s as a complementary and alternative platform to the current egg-based strategies.

<span class="mw-page-title-main">Natteri Veeraraghavan</span>

Natteri Veeraraghavan (1913-2004) was an Indian physician, microbiologist and medical researcher, known for his contributions to the understanding of diseases like rabies, tuberculosis and leprosy. He was a former director of the Pasteur Institute of India, Coonoor and the chairman of the World Health Organization International Reference Center on Rabies. He was honoured by the Government of India in 1967, with the award of Padma Shri, the fourth highest Indian civilian award for his contributions to the society.

Intrastructural help (ISH) is where T and B cells cooperate to help or suppress an immune response gene. ISH has proven effective for the treatment of influenza, rabies related lyssavirus, hepatitis B, and the HIV virus. This process was used in 1979 to observe that T cells specific to the influenza virus could promote the stimulation of hemagglutinin specific B cells and elicit an effective humoral immune response. It was later applied to the lyssavirus and was shown to protect raccoons from lethal challenge. The ISH principle is especially beneficial because relatively invariable structural antigens can be used for the priming of T-cells to induce humoral immune response against variable surface antigens. Thus, the approach has also transferred well for the treatment of hepatitis B and HIV.

<span class="mw-page-title-main">Vaccination in India</span>

Vaccination in India includes the use of vaccines in Indian public health and the place of vaccines in Indian society, policy, and research.

References

  1. "Medico Friend Circle" (PDF). June–July 2008.
  2. "Vaccine Worries". The Hindu. Retrieved 11 April 2008.
  3. "National Institute of Nutrition".
  4. "Europepmc".
  5. "ICMR approved Laboratories" (PDF). Archived from the original (PDF) on 28 July 2020. Retrieved 29 April 2020.